Technical Analysis for BWAY - Brainsway Ltd.

Grade Last Price % Change Price Change
A 10.23 2.30% 0.23
BWAY closed up 2.3 percent on Friday, November 1, 2024, on approximately normal volume.
Earnings due: Nov 13
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction 2.30%
Inside Day Range Contraction 2.30%
Gapped Up Strength 2.30%
Shooting Star Candlestick Bearish 2.81%
Bollinger Band Squeeze Range Contraction 2.81%

   Recent Intraday Alerts

Alert Time
Up 1% about 18 hours ago
10 DMA Support about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago
Down 1% about 21 hours ago
Gap Up Closed 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Brainsway is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which Brainsway received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 (for MDD) and in August 2018 (for OCD). Brainsway is currently conducting clinical trials of Deep TMS in other psychiatric, neurological and addiction disorders, including smoking cessation and post-traumatic stress disorder, and is planning trials for opioid addiction, fatigue in multiple sclerosis (MS) and post-stroke rehabilitation.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Neuroscience FDA Mental Health Opioids Multiple Sclerosis Psychiatry Stroke Major Depressive Disorder Neuromodulation Neurophysiology Depressive Disorder Neurotechnology Smoking Post Traumatic Stress Disorder Neuropsychology Smoking Cessation Treatment Of Major Depressive Disorder Obsessive Compulsive Disorder Addiction Neuromodulation Products Treatment Of Depression Non Invasive Neuromodulation Products

Is BWAY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.61
52 Week Low 3.78
Average Volume 86,064
200-Day Moving Average 6.80
50-Day Moving Average 8.81
20-Day Moving Average 9.76
10-Day Moving Average 9.89
Average True Range 0.46
RSI (14) 64.91
ADX 42.81
+DI 29.42
-DI 9.47
Chandelier Exit (Long, 3 ATRs) 9.24
Chandelier Exit (Short, 3 ATRs) 10.31
Upper Bollinger Bands 10.34
Lower Bollinger Band 9.18
Percent B (%b) 0.9
BandWidth 11.96
MACD Line 0.35
MACD Signal Line 0.38
MACD Histogram -0.0249
Fundamentals Value
Market Cap 170.03 Million
Num Shares 16.6 Million
EPS -0.48
Price-to-Earnings (P/E) Ratio -21.31
Price-to-Sales 3.45
Price-to-Book 2.44
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.25
Resistance 3 (R3) 11.24 10.89 11.08
Resistance 2 (R2) 10.89 10.63 10.90 11.02
Resistance 1 (R1) 10.56 10.47 10.73 10.57 10.97
Pivot Point 10.21 10.21 10.29 10.22 10.21
Support 1 (S1) 9.88 9.95 10.05 9.89 9.49
Support 2 (S2) 9.53 9.79 9.54 9.44
Support 3 (S3) 9.20 9.53 9.38
Support 4 (S4) 9.21